Prognostic Impact of Pelvic Lymph Node Dissection During Radical Prostatectomy on Patients With High-risk Prostate Cancer Treated With Neoadjuvant …
H Iwamura, S Hatakeyama, T Narita, Y Ozaki, S Konishi… - 2021 - researchsquare.com
Background We aimed to determine the prognostic and staging benefit of limited pelvic
lymph node dissection (PLND) during radical prostatectomy (RP) in high-risk prostate …
lymph node dissection (PLND) during radical prostatectomy (RP) in high-risk prostate …
[HTML][HTML] Positive Association between Preoperative Total Testosterone and Lymph Node Invasion in Intermediate Risk Prostate Cancer
AB Porcaro, A Tafuri, M Sebben, P Corsi, T Processali… - Current …, 2019 - karger.com
Abstract Introduction: Prostate cancer (PCa) patients who are classified into the intermediate
risk category represent a heterogeneous population needing further preoperative risk …
risk category represent a heterogeneous population needing further preoperative risk …
Is the Age of Extended Pelvic Lymph Node Dissection Over? The Devil Is in the Details
G Devos, A Clinckaert… - European …, 2021 - euoncology.europeanurology.com
In this issue of European Urology Oncology, Touijer et al [1] report on limited versus
extended pelvic lymph node dissection (PLND) for prostate cancer (PCa). In this large …
extended pelvic lymph node dissection (PLND) for prostate cancer (PCa). In this large …
Sterol O-Acyltransferasen als Zielmoleküle in der Tumortherapie sowie die klinische Relevanz ihrer Expression beim Prostatakarzinom
C Eckhardt - 2021 - opus.bibliothek.uni-wuerzburg.de
Sterol O-Acyltransferasen (SOATs) spielen eine zentrale Rolle im Cholesterinstoffwechsel
von Zellen, indem sie die Veresterung von freiem Cholesterin und Speicherung in Lipid …
von Zellen, indem sie die Veresterung von freiem Cholesterin und Speicherung in Lipid …
Generation of CRISPR engineered prostate cancer cell line models to study androgen receptor signalling in advanced prostate cancer
EE Kounatidou - 2020 - theses.ncl.ac.uk
Prostate cancer resistance to AR targeted therapies due to the emergence of AR point
mutations and AR splice variants that cannot be targeted by the currently available agents …
mutations and AR splice variants that cannot be targeted by the currently available agents …
Valor Preditivo de Marcadores de Transição Epitelial-Mesenquimatosa, PTEN, ERG, KI-67 e de Estudo Mutacional, na Recorrência Bioquímica de Carcinoma da …
NJSS de Oliveira - 2018 - search.proquest.com
Introdução: O carcinoma da próstata apresenta uma elevada incidência e prevalência. A
maioria dos carcinomas da próstata localizados são curáveis, com as opções terapêuticas …
maioria dos carcinomas da próstata localizados são curáveis, com as opções terapêuticas …